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Purpose. Totally endoscopic management (all-endo) of patients with a duplicated renal system (DS) associated with severe
vesicoureteral reﬂux (VUR) or obstructive ureterocele (UC) is an attractive alternative to traditional open procedures. The authors
discuss feasibility and results of an all-endo approach on a consecutive series of patients. Methods. From 1999 to 2009, all patients
with a complete DS associated with UC and/or VUR were proposed for primary all-endo approach. UC puncture was performed
using a 3Fr Bugbee electrode. Deﬂux (dextranomer/hyaluronic acid copolymer) injection was administered for VUR. The need
for secondary surgery was evaluated on followup. Results. Of the 62 patients recruited, 46 were treated using a primary all-
endo approach and 16 patients received no treatment. Of the 46 treated patients with 56 aﬀected renal units, 32 (97%) UCs
collapsed following puncture and 29 (63%) VURs were resolved or downgraded. Secondary VUR occurred in 13 (39%) renal
units. Secondary surgery was performed on 23 (41%) renal units. Conclusion. The all-endo approach for VUR in DS is an eﬀective
therapeutic option. UC collapse was achieved by puncture in most of the patients; secondary VUR was the main complication in
as m a l lg r o u po fe x t r a v e s i c a lU C .
1.Introduction
There is wide debate on the management of patients with
a complete duplicated pyeloureteral system (DS) associated
with ureterocele (UC) and/or major vesicoureteral reﬂux
(VUR), and consensus on this matter has not yet been
reached [1–5]. This may be due to the wide spectrum of
anatomical and clinical features observed in aﬀected patients
and the need for an individualized approach. As far as the
endoscopic approach to treatment is concerned, the use
of UC puncture to relieve obstruction, control infection,
and recover renal function is hampered by controversial
outcomes and side eﬀects [6]. Secondary VUR and the need
for subsequent intravesical surgery have been reported by
several studies [6, 7]. In contrast, a conservative approach
to the treatment of certain types of UC has been gaining
favour [3]. Treatment of VUR associated with a duplex
pyeloureteral system, with or without concomitant UC, is
another matter for debate. Endoscopic intrameatal injection
of bulking agents was reported to be less eﬀective than in
a single system when used to treat VUR [8]. During the
last decade, the treatment policy at our institution has been
to consider minimally invasive all-endo management as the
primaryoptionforthisgroupofurinarytractanomalies.The
aim of our study was to investigate the feasibility, limitations,
and possible advantages of this approach.
2. Methods
2.1. Patients and Treatments. From 1999 to 2009, patients
with unilateral or bilateral complete DS associated with UC
and/or VUR were recruited. Informed consent was acquired
for each patient. Preliminary examinations included ultra-
sonography and voiding cystourethrogram (VCUG). The
grade and side of VUR were recorded. Dilated dupli-
cated system, position (intra- or extravesical), and size
of UC were established. A 99mTc-mercaptoacetyltriglycine2 International Journal of Pediatrics
(MAG3) diuretic renal scan was used in all UCs with a
dilated upper system. A 99mTc-dimercaptosuccinic acid
(DMSA) renal scan was performed in all VUR to evaluate
scar formation. Urinary magnetic resonance imaging was
undertaken in patients with unclear anatomy and poor
renal function. After initial conservative management, a
primaryall-endotreatmentapproachwaselectedforselected
patients.CommonindicationstoperformUCpuncturewere
a dilated upper system and recurrent urinary infections or
an obstructive renographic pattern in a still functional renal
moiety. Endoscopic treatment was indicated for patients
with persistent grade ≥III VUR and recurrent urinary tract
infections following antibiotic prophylaxis. Three treatment
options were available: puncture alone, puncture and Deﬂux
(Oceana Therapeutics, Inc., Edison, USA. [submucosal, in-
trameatal dextranomer/hyaluronic acid copolymer]) injec-
tion, and Deﬂux injection only. UC puncture was performed
on the lower portion using a 3Fr Bugbee electrode. Deﬂux
injectioninthereﬂuxingureterwasthepreferredendoscopic
procedure.
UC size and upper tract dilatation were monitored twice
a month after endoscopic puncture using ultrasonography;
possible occurrence of secondary VUR was monitored by
VCUG at one month. The MAG3 diuretic scan was re-
peated after 3 months. Results of VUR treatment were
monitored by VCUG 3–6 months after Deﬂux injection.
Patients underwent a repeat DMSA scan 6 months after
conservative treatment and 12 months after successful endo-
scopic management. Secondary open surgery was considered
if the endoscopic approach was unsuccessful. Whenever
a simultaneous all-endo treatment of UC and VUR was
performed, a control MAG3 scan was only used to check
postoperative split function.
2.2. Statistical Analysis. The outcome of a primary all-endo
approach was correlated with DS variants (the grade of
associated VUR; position and anatomy of associated UC).
Data were analyzed with GraphPad InStat software (version
3.10) (GraphPad Software, Inc., La Jolla, USA). The chi-
square test used for univariate comparisons. Fisher’s exact
test was used comparisons of categorical variables.
Multipleregressiontestswereusedforfactorsinﬂuencing
outcome. P<0.05 was considered signiﬁcant.
3. Results
3.1. Patient Characteristics. A total of 62 patients, with
male:female ratio of 43:19 and a mean age at referral of
18 months, (range 1–96 months), were recruited. Detection
of hydronephrosis by antenatal ultrasonography led to the
enrollment of 45 patients (73%); all other patients (n = 17,
27%) were enrolled because of a history of febrile urinary
tract infections. Among the 62 patients with documented
DS, 40 patients had a UC of the upper moiety. Twenty-three
UCs were on the right side (extravesical n = 12; intravesical
n = 11), and 17 were on the left side (extravesical n = 9;
intravesical n = 8). No bilateral cases were observed. VUR
was associated with DS in 44 patients, occurring on the right
side in 26 patients (grade II n = 3; grade III n = 10; grade
IV n = 9; grade V n = 4) and on the left side in 18 patients
(grade II n = 6, grade III n = 3, grade IV n = 8, and grade
V n = 2). In one patient, VUR aﬀected both renal districts
of the left DS. No treatment was required in 16 patients.
Among these patients there were six nonobstructive small
intravesical UCs and one extravesical UC corresponding to
a multicystic upper moiety. Asymptomatic grade I–III VUR
aﬀecting 12 lower renal moieties reduced spontaneously
within 6 months after diagnosis.
3.2. Treatments. An all-endo primary treatment approach
was elected for 46 patients (32 boys and 14 girls). Of
these patients, 30 (65%) were enrolled following antenatal
ultrasonography diagnosis of DS and/or UC at birth. Mean
age at ﬁrst treatment was 39 months (range 1–95 months).
Among these patients, 9 had complete bilateral DS and 37
had complete unilateral DS. Forty-three unilateral UCs were
observed. Twenty extravesical UCs were punctured; 12 of
these UCs were associated with grade ≥III VUR in the lower
pole and these patients underwent simultaneous endoscopic
VUR correction. Thirteen intravesical UCs were punctured,
11 of which were associated with grade ≥III VURs in the
lower moiety, which were treated endoscopically during the
procedure. VUR not associated with UC was recorded in
23 renal moieties in 22 patients with DS. The lower renal
moiety was involved in 21 of these patients, and both renal
moieties were involved in the remaining patient. Deﬂux
injections were administered to each aﬀected renal unit. The
procedure was repeated 4 months after the initial injection
in 6 patients for a persisting grade ≥III VUR or for a lower
grade associated with UTI. The outcome of the all-endo
primary treatment approach to 56 renal units aﬀected by UC
and/or grade ≥III VUR is shown in Table 1.
In the 46 patients with DS associated with UC and/or
VUR, the primary all-endo treatment was successful and
resolutive in 23 (50%). For a further 17 (37%) patients
this treatment strategy resolved breakthrough urinary tract
infection and urinary obstruction and delayed the need
for open reconstructive surgery. Only 6 patients (13%)
with persistent severe VUR required secondary total or
partial demolitive surgery for severe renal dysplastic changes.
Factors aﬀecting the outcome of the all-endo management
approach and the rate of secondary surgery are shown in
Table 2.
Endoscopic treatment of VUR by Deﬂux injection and
puncture or Deﬂux injection alone was successful in 63%
of renal units treated (n = 29). The outcome of all-endo
management was signiﬁcantly inﬂuenced by the grade of
VUR (P = 0.0261). UC collapse after puncture occurred
in 32/33 renal units (97%), but secondary VUR occurred
in only 13 of these patients (39%). The occurrence of
this complication was signiﬁcantly correlated with UC
position and anatomy (extravesical more than intravesical;
P = 0.0315). UC position and anatomy also signiﬁcantly
inﬂuenced the need for secondary open surgical procedures
in 23/56 renal units (41%; P = 0.019). In 14 of them
there was an extravesical UC, in 12 an initial high-gradeInternational Journal of Pediatrics 3
Table 1: Details of the all-endo treatment approach for duplicated renal unit.
Pathology Number of renal units Procedure
Number of renal units interested (%)
UC collapses after
puncture
VUR resolved or
downgraded
Secondary VUR
after UC
puncture
Secondary
surgery
DS-UC 10 Puncture 9 (90) — 5 (50) 5 (50)
DS-UC-VUR 23 Puncture &
Deﬂux injection 23 (100) 11 (48) 8 (35) 13 (57)
DS-VUR 23 Deﬂux injection — 18 (78) — 5 (22)
Total 56 — 32/33 (97) 29/46 (63)a 13/33 (39) 23/56 (41)
a2 Deﬂux injections were performed in 6 patients; DS: duplicated renal system; UC:u r e t e r o c e l e ;VUR:v e s i c o u r e t e r a lr e ﬂ u x .
Table 2: Factors aﬀecting the outcome of the all-endo approach and the need for secondary surgical intervention.
Outcome No. of renal units (%) Ureterocele position and anatomy VUR grade in lower moiety
VUR resolved or downgraded 29/46 (63) NS P = 0.0261
Secondary VUR after UC puncture 13/33 (39) P = 0.0315 NS
Required open surgery 23/56 (41) P = 0.019 NS
NS: not statistically signiﬁcant; UC:u r e t e r o c e l e ;V U R :v e s i c o u r e t e r a lr e ﬂ u x .
Table 3: Type and details of secondary surgery performed.
Type of surgical intervention No. of renal units Indications
Double vesicoureteral reimplant 18 Persistent lower pole VUR (n = 14) and/or secondary
u p p e rp o l eV U R( n = 6)
Upper pole nephrectomy 1 Secondary upper pole VUR and severe dysplasia
Upper pole nephrectomy and lower pole reimplant 2 Upper pole dysplasia and persistent lower pole VUR
(n = 2)
Pyelopyelic anastomosis 1 Persisting UC and dilatation
Nephroureterectomy 3 Severe dysplasia
UC ureterocele;V U Rvesicoureteral reﬂux.
(≥IV)VURinthelowerpole.Twenty-ﬁvesecondarysurgical
procedures were required (Table 3) mainly due to persisting
high-grade primary VUR in the lower pole. Surgery was
rarely required to treat secondary iatrogenic VUR in the
upper pole occurring after UC puncture.
4. Discussion
Recent thinking on an endoscopic approach to DS associated
with UC and/or VUR continues to be controversial. Surgery
at the bladder level has been advocated for large extravesical
UC of the upper pole associated with high-grade VUR in
the lower pole [9–11]. After introduction of laparoscopic
approach, upper pole nephrectomy has been increasingly
advisedforisolatedextravesicalUCwithabsentorpoorrenal
function in the corresponding renal moiety without VUR in
the lower pole. This aggressive attitude must be tempered
considering that many unobstructed, uninfected UC with
conserved renal function or a nonfunctioning dysplastic
upper pole may be candidates for nonsurgical therapy, [3]
with many cases reported to resolve spontaneously [12].
The endoscopic puncture of an obstructive UC leads to
recovery of renal function in a proportion of patients [7, 13,
14]. Additionally, VUR in the lower moiety associated with
upper pole UC has been reported to resolve or downgrade
following puncture in 48% of patients [5]. Criticism of
primary UC puncture is mainly based on the high rate of
reoperation, which is required in approximately half of all
cases of extravesical UCs and whenever lower pole VUR
is associated with UC. Use of this procedure is therefore
restricted to the emergency treatment of the UC or the
elective management of some patients with intravesical UCs.
A recent meta-analysis of surgical practice patterns in the
endoscopic management of UC concluded that the UC
location (extravesical versus intravesical) and renal anatomy,
together with preoperative lower pole VUR, are proxies for
trigonal distortion, which is accompanied by an increased
risk of reoperation [1]. As far as VUR in DS is concerned,
the outcome in patients with lower grade VUR was similar
to that seen in patients with a single renal system, and this
justiﬁes the conservative management approach [2]. Indeed,
endoscopic treatment of higher-grade lower pole VUR in
patients with DS has been reported to have a success rate of
73%[4,15–17].WheneverUCoftheupperpoleisassociated
with lower moiety VUR, over 70% of patients respond to
endoscopic correction after UC endoscopic puncture [5].
In conclusion a conservative approach can be the primary
option for small nonobstructive intravesical UC and for4 International Journal of Pediatrics
those extravesical UC corresponding to a multicystic upper
moiety without any bladder outlet obstruction. Even asymp-
tomatic mild VUR in the lower moiety, can be preferably
left alone, and spontaneous resolution can be expected. In
all other cases of complete ureteral duplications complicated
by UC and/or VUR an all-endo approach is a feasible option
andreducestheneedformajoropen orlaparoscopicsurgery.
Diﬃculties correlated with individual anatomical variations
andsometimeswithseveretrigonaldistortionmustbealways
considered;theyrequireexperiencedhandsandmaydemand
multiple procedures.
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